ARCHIVES

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

This article is from The Cancer Letter archive.

Vol. 22 No. 35 | September 13, 1996

Download PDF Visit The Full Archive

Related Articles

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

DCT Board Approves New RFA For Aids Clinical Trials Groups

November 11, 1994

What Research Will, Will Not Be Funded At Various Levels – FY 1997 ZBB

October 14, 1977

Stereotactic Body Radiotherapy Could Improve Overall Survival

July 29, 2011

National Academies: Changes Required To Reduce Incidence Of Medical Errors, Report Finds

December 3, 1999

Duke Officials Decline To Provide Details Of Probe

July 23, 2010